Overview

Companion Animal Specialty Drugs Market is predicted to value over USD xx billion by 2027 end with a CAGR of over xx% during the forecast period 2020 to 2027.

Increased developments in advanced biologics technologies like recombinant DNA vaccines is the primary factor responsible for the growth of the market. A companion animal is primarily referred to a dog or a cat or those who are domesticated near the household of the person caring for them. Rising awareness regarding animal healthcare in developed as well as developing countries along with the increased demand for compounded drugs shall boost the companion animal specialty drugs market growth. DNA vaccines used for dogs are predicted to increase the demand for veterinary vaccine specialities. The recombinant vaccines offer novel protection to petting animals. Such factors are responsible for the growth of the market. 
As per a survey performed in 2012, over 40% of children aged five years were reported to look for their pets when they felt sad or happy. Furthermore, as per the survey conducted by the Animal Pet Products Association in 2012, over 60% of householders in the United States own single or multiple companion animals. Advantages of owing a companion animal, increased urbanization and rising number of nuclear families are some of the reasons responsible for the proliferation of the market.

Market Segmentation:

By Product Type 
•    Vaccines
•    Anti-Inflammatory Drugs
•    Animal Feed Additives
•    Antibiotics
•    Skin Care Products 
•    Parasiticides
•    Others
By Distribution Channel
•    Veterinary Clinics    
•    Hospital Pharmacies
•    Drug Stores    
By Region
•    North America
•    Europe
•    Asia-Pacific
•    Latin America
•    Middle East and Africa

The market is classified into distribution channel, product type and region. The product type segment is fragmented into vaccines, anti-inflammatory drugs, animal feed additives, antibiotics, skin care products, skin care products, parasiticides and others.  The distribution channel segment is categorised into veterinary clinics, hospital pharmacies and drug stores. The veterinary clinics segment is predicted to account the largest companion animal specialty drugs market share during the forecast period.

Regional Analysis:

The North America region is estimated to lead the market during the forecasted timeframe, and this can be credited to the increased number of companion animal ownerships in households of the United States. Furthermore, with people living a stressful lifestyle in developed nations like the US, owing a pet provides the necessary emotional support which has bolstered the market growth in the region.

Competitive Landscape:                            

Some of the prominent market players are Zoetis Inc., Merck & Co., Inc., Bayer AG, Elanco (a division of Eli Lilly & Company), Boehringer Ingelheim Animal Health Gmbh, Ceva Sante Animale S.A., Aratana Therapeutics, Merial, The J.M Smucker Company, Mars, Beaphar.

FutureWise Key Takeaways:

•    Growth prospects
•    SWOT analysis 
•    Key market trends 
•    Key data-points affecting market growth

Objectives of the Study:

•    To provide with an exhaustive analysis on the global companion animal specialty drugs market by product type, by distribution channel and by region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
•    To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions   

Flexible Delivery Model:

•    We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•    The customization Mobility Care offered are free of charge with purchase of any license of the report
•    You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
         1.1 Objectives of the Study 
         1.2 Market Definition 
         1.3 Market Scope 
                1.3.1 Years Considered for the Study
                1.3.2 Market Covered
         1.4 Currency 
         1.5 Limitations 
         1.6 Stakeholders 
2.  Research Methodology 
         2.1 Research Data 
             2.1.1 Secondary Data
                      2.1.1.1 Key Data from Secondary Sources
             2.1.2 Primary Data
                         2.1.2.1 Key Data from Primary Sources
         2.2 Market Size Estimation 
         2.3 Market Breakdown and Data Triangulation 
         2.4 Assumptions for the Study  
3. Executive Summary
         3.1 Market Outlook
         3.2 Segment Outlook
         3.3 Competitive Insights
4. Market Variables, Trends & Scope
         4.1 Market Lineage Outlook
         4.2 Penetration and Growth Prospect Mapping
         4.3 Industry Value Chain Analysis
         4.4 Cost Analysis Breakdown
         4.5 Technology Overview
         4.6 Regulatory Framework on Country Level
                 4.6.1 Reimbursement Framework    
                 4.6.2 Standards and Compliances
5. Market Overview
         5.1 Market Dynamics
             5.1.1 Market Driver Analysis
             5.1.2 Market Restraint Analysis
             5.1.3 Industry Challenges                   
6. Market Analysis tools                       
         6.1 Industry Analysis - Porter’s
                     6.1.1 Supplier Power
                     6.1.2 Buyer Power
                     6.1.3 Substitution Threat
                     6.1.4 Threat from new entrants
                     6.1.5 Competitive Rivalry                  
         6.2 Pestel Analysis
                     6.2.1 Political Landscape
                     6.2.2 Environmental Landscape
                     6.2.3 Social landscape
                     6.2.4 Technology landscape
                     6.2.5 Legal Landscape
7. Companion Animal Specialty Drugs Market, By Product Type Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
         7.1 Vaccines
         7.2 Anti-Inflammatory Drugs
         7.3 Animal Feed Additives
         7.4 Antibiotics
         7.5 Skin Care Products 
         7.6 Parasiticides
         7.7 Others     
8. Companion Animal Specialty Drugs Market, By Distribution Channel Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
         8.1 Veterinary Clinics    
         8.2 Hospital Pharmacies
         8.3 Drug Stores                                       
9. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
         9.1. Introduction
         9.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019
                9.2.1. U.S.
                9.2.2. Canada
                9.2.3. Mexico
                9.2.4 Rest of North America
         9.3 Market Size (USD Mn) Forecast for North America 2020-2027
10. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
         10.1. Introduction
         10.2. Regional Market Trends
         10.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019
                10.3.1. Brazil
                10.3.2. Uruguay
                10.3.3 Argentina
                10.3.4. Rest of Latin America
         10.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027
11. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
         11.1. Introduction
         11.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019
                11.2.1. Germany
                11.2.2. U.K
                11.2.3. France
                11.2.4. Italy
                11.2.5 Switzerland
                11.2.6. Spain
                11.2.7. Russia
                11.2.8. Poland
                11.2.9. Rest of Western Europe
          11.3 Market Size (US$ Mn) Forecast for Europe 2020-2027
12. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
          12.1 Introduction
          12.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019
                 12.2.1 Japan
                 12.2.2 China
                 12.2.3 Singapore
                 12.2.4 Korea         
                 12.2.5 India
                 12.2.6 Australia and New Zealand
                 12.2.7 ASEAN
                 12.2.8 Rest of Asia Pacific
          12.3 Market Size (US$ Mn) Forecast for Asia Pacific 2020-2027
13. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
          13.1 Introduction
          13.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019
              13.2.1 UAE
              13.2.2 South Africa
              13.2.3 Egypt
              13.2.4 Saudi Arabia
              13.2.5 Rest of MEA
          13.3 Market Size (US$ Mn) Forecast for MEA 2020-2027
14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
    14.1 Zoetis Inc.
            14.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.1.2. Product Portfolio
            14.1.3. SWOT Analysis
            14.1.4. Financial Overview
            14.1.5. Strategic Overview
    14.2 Merck & Co., Inc.
            14.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.2.2. Product Portfolio
            14.2.3. SWOT Analysis
            14.2.4. Financial Overview
            14.2.5. Strategic Overview
    14.3 Bayer AG
            14.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.2. Product Portfolio
            14.3.3. SWOT Analysis
            14.3.4. Financial Overview
            14.3.5. Strategic Overview
    14.4 Elanco
            14.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.4.2. Product Portfolio
            14.4.3. SWOT Analysis
            14.4.4. Financial Overview
            14.4.5. Strategic Overview
    14.5 Boehringer Ingelheim Animal Health Gmbh
            14.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.5.2. Product Portfolio
            14.5.3. SWOT Analysis
            14.5.4. Financial Overview
            14.5.5. Strategic Overview
    14.6 Ceva Sante Animale S.A.
            14.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.6.2. Product Portfolio
            14.6.3. SWOT Analysis
            14.6.4. Financial Overview
            14.6.5. Strategic Overview
    14.7 Aratana Therapeutics
            14.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.7.2. Product Portfolio
            14.7.3. SWOT Analysis
            14.7.4. Financial Overview
            14.7.5. Strategic Overview
    14.8 Merial
            14.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.8.2. Product Portfolio
            14.8.3. SWOT Analysis
            14.8.4. Financial Overview
            14.8.5. Strategic Overview    
    14.9 The J.M Smucker Company
            14.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.9.2. Product Portfolio
            14.9.3. SWOT Analysis
            14.9.4. Financial Overview
            14.9.5. Strategic Overview
    14.10 Beaphar
            14.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.10.2. Product Portfolio
            14.10.3. SWOT Analysis
            14.10.4. Financial Overview
            14.10.5. Strategic Overview
15 Impact of COVID-19
     15.1. Positive influence on the healthcare industry
     15.2. The financial disruption of the manufacturing sector
     15.3. Impact of COVID-19 on emerging companies
     15.4. Significant mandates in the healthcare regulations initiated by administrations
     15.5. The overall economic slowdown of the developing and developed nations
16. Competitive Intelligence and Competitive Matrix
     16.1 Competitive Intelligence
     16.2 Competitive Matrix
17. Major Deals and Strategic Alliances Analysis
     17.1 Joint ventures
     17.2 Mergers and acquisitions
     17.3 Licensing and partnerships 
     17.4 Technology Collaborations
     17.5 Strategic Divestments
     17.6 Market Entry Strategies                  
18. Relevant Case Studies and Latest News Updates     
19. Key Market Takeaway Points from the Market Analysts at Future Market Analytics

Tables

Figures